Multimodality cardiovascular molecular imaging technology

Journal of Nuclear Medicine

Volumn 51, Issue SUPPL.1, 2010, Pages

  O'Donnell, Matthew ^a   McVeigh, Elliot R ^b   Strauss, H William ^c   Tanaka, Atsushi ^d   Bouma, Brett E ^e,f   Tearney, Guillermo J ^e,f   Guttman, Michael A ^g   Garcia, Ernest V ^h  

^a UNIVERSITY OF WASHINGTON   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g Surgivision Inc   (United States)

^h EMORY UNIVERSITY   (United States)

Author keywords

Cardiovascular; Molecular imaging; Multidisciplinary approach

Indexed keywords

CONTRAST MEDIUM;

CARDIAC IMAGING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; HEART SURGERY; MOLECULAR IMAGING; MOLECULAR PROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RADIATION DETECTOR; REVIEW; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING; ULTRASOUND; ACOUSTICS; ANIMAL; BIOLOGICAL MODEL; COMPUTER GRAPHICS; COMPUTER INTERFACE; DIAGNOSTIC IMAGING; ECHOGRAPHY; HUMAN; IMAGE PROCESSING; METHODOLOGY; OPTICAL TOMOGRAPHY; PATHOLOGY;

ACOUSTICS; ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; COMPUTER GRAPHICS; CONTRAST MEDIA; DIAGNOSTIC IMAGING; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MODELS, BIOLOGICAL; TOMOGRAPHY, OPTICAL; ULTRASONOGRAPHY; USER-COMPUTER INTERFACE;

EID: 77953031624     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.068155     Document Type: Review

References (66)

1. Ellegala DB, Leong-Poi H, Carpenter JE, et al. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to avb3. Circulation. 2003;108:336-341.
2. Winter PM, Cai K, Caruthers SD, Wickline SA, Lanza GM. Emerging nanomedicine opportunities with perflourocarbon nanoparticles. Expert Rev Med Devices. 2007;4:137-145.
3. Agarwal A, Huang SW, O'Donnell M, et al. Targeted gold nano-rod contrast agent for prostate cancer detection by photoacoustic imaging. J Appl Phys. 2007;102:064701-1-064701-4.
4. Kruger RA. Photo-acoustic ultrasound: pulse production and detection in 0.5% Liposyn. Med Phys. 1994;21:1179-1184.
5. Oraevsky AA, Jacques SL, Esenaliev RO, Tittel FK. Time resolved optoacoustic imaging in layered biological tissues. OSA Proc Adv Opt Imaging Photon Migration. 1994;21:161-165.
6. Kim K, Agarwal A, Huang S-W, et al. Photoacoustic imaging of early inflammatory response using gold nanorods. Appl Phys Lett. 2007;90:223901.
7. Kim K, Agarwal A, McDonald AM, et al. In vivo imaging of inflammatory responses by photoacoustics using cell-targeted gold nanorods (GNR) as contrast agent. Proc SPIE. 2008;6856:68560H.
8. Ashkenazi S, Hou Y, Huang S-W, Buma T, O'Donnell M. High frequency optoacoustic transducers for ultrasonic and photoacoustic imaging and spectroscopy. In: Wang L, ed. Optical Science and Engineering. Oxford, U.K.: CRC Press; 2009:223-238.
9. Hou Y, Kim J-S, Ashkenazi S, Huang SW, Guo LJ, O'Donnell M. Broadband all-optical ultrasound transducers. Appl Phys Lett. 2007;91:073507.
10. Hou Y, Kim J-S, Huang SW, Ashkenazi S, Guo LJ, O'Donnell M. Characterization of a broadband all-optical ultrasound transducer : from optical and acoustical properties to imaging. IEEE Trans Ultrason Ferroelectr Freq Control. 2008;55:1867-1877.
11. Lederman RJ, Guttman MA, Peters DC, et al. Catheter-based endomyocardial injection with real-time magnetic resonance imaging. Circulation. 2002;105:1282-1284.
12. Kraitchman DL, Heldman AW, Atalar E, et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation. 2003;107:2290-2293.
13. Dick AJ, Guttman MA, Raman VK, et al. Magnetic resonance fluoroscopy allows targeted delivery of mesenchymal stem cells to infarct borders in swine. Circulation. 2003;108:2899-2904.
14. Elgort DR, Hillenbrand CM, Zhang S, et al. Image-guided and -monitored renal artery stenting using only MRI. J Magn Reson Imaging. 2006;23:619-627.
15. Zuehlsdorff S, Umathum R, Volz S, et al. MR coil design for simultaneous tip tracking and curvature delineation of a catheter. Magn Reson Med. 2004;52:214-218.
16. Atalar E, Kraitchman DL, Carkhuff B, et al. Catheter-tracking FOV MR fluoroscopy. Magn Reson Med. 1998;40:865-872.
17. Hillenbrand CM, Elgort DR, Wong EY, et al. Active device tracking and high-resolution intravascular MRI using a novel catheter-based, opposed-solenoid phased array coil. Magn Reson Med. 2004;51:668-675.
18. Guttman MA, Ozturk C, Raval AN, et al. Interventional cardiovascular procedures guided by real-time MR imaging: an interactive interface using multiple slices, adaptive projection modes and live 3D renderings. J Magn Reson Imaging. 2007;26:1429-1435.
19. McVeigh ER, Guttman MA, Lederman RJ, et al. Real-time interactive MRI-guided cardiac surgery: aortic valve replacement using a direct apical approach. Magn Reson Med. 2006;56:958-964.
20. Horvath KA, Li M, Mazilu D, Guttman MA, McVeigh ER. Real-time magnetic resonance imaging guidance for cardiovascular procedures. Semin Thorac Cardiovasc Surg. 2007;19:330-335.
21. Guttman MA, Lederman RJ, Sorger JM, McVeigh ER. Real-time volume rendered MRI for interventional guidance. J Cardiovasc Magn Reson. 2002;4:431-442.
22. Raman VK, Karmarkar PV, Guttman MA, et al. Real-time magnetic resonance-guided endovascular repair of experimental abdominal aortic aneurysm in swine. J Am Coll Cardiol. 2005;45:2069-2077.
23. Raval AN, Karmarkar PV, Guttman MA, et al. Real-time magnetic resonance imaging-guided endovascular recanalization of chronic total arterial occlusion in a swine model. Circulation. 2006;113:1101-1107.
24. Raval AN, Karmarkar PV, Guttman MA, et al. Real-time MRI guided atrial septal puncture and balloon septostomy in swine. Catheter Cardiovasc Interv. 2006;67:637-643.
25. Hill JM, Dick AJ, Raman VK, et al. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation. 2003;108:1009-1014.
26. Zaret BL, Strauss HW, Martin ND, Wells HP Jr, Flamm MD Jr. Noninvasive regional myocardial perfusion with radioactive potassium: study of patients at rest, with exercise and during angina pectoris. N Engl J Med. 1973;288:809-812.
27. Brown KA, Boucher CA, Okada RD, et al. Prognostic value of exercise thallium-201 imaging in patients for evaluation of chest pain. J Am Coll Cardiol. 1983;1:994-1001.
28. Yoshinaga K, Chow BJ, Williams K, et al. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J Am Coll Cardiol. 2006;48:1029-1039.
29. Hartung D, Schäfers M, Fujimoto S, et al. Targeting of matrix metalloproteinase activation for noninvasive detection of vulnerable atherosclerotic lesions. Eur J Nucl Med Mol Imaging. 2007;34(suppl 1):S1-S8.
30. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol. 2006;47(8, suppl):C13-C18.
31. Spagnoli LG, Bonanno E, Sangiorgi G, Mauriello A. Role of inflammation in atherosclerosis. J Nucl Med. 2007;48:1800-1815.
32. Ohtsuki K, Hayase M, Akashi K, Kopiwoda S, Strauss HW. Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: an autoradiographic study. Circulation. 2001;104:203-208.
33. Blankenberg FG, Tait JF, Blankenberg TA, Post AM, Strauss HW. Imaging macrophages and the apoptosis of granulocytes in a rodent model of subacute and chronic abscesses with radiolabeled monocyte chemotactic peptide-1 and annexin V. Eur J Nucl Med. 2001;28:1384-1393.
34. Blankenberg FG, Wen P, Dai M, et al. Detection of early atherosclerosis with radiolabeled monocyte chemoattractant protein-1 in prediabetic Zucker rats. Pediatr Radiol. 2001;31:827-835.
35. Rudd JH, Myers KS, Bansilal S, et al. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study. Circ Cardiovasc Imaging. 2009;2:107-115.
36. Strauss HW, Mari C, Patt BE, Ghazarossian V. Intravascular radiation detectors for the detection of vulnerable atheroma. J Am Coll Cardiol. 2006;47(8, suppl):C97-C100.
37. Janecek M, Patt BE, Iwanczyk JS, et al. Intravascular probe for detection of vulnerable plaque. Mol Imaging Biol. 2004;6:131-138.
38. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-1780.
39. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-1323.
40. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503-1516.
41. Fuster V, Badimon L, Cohen M, Ambrose JA, Badimon JJ, Chesebro J. Insights into the pathogenesis of acute ischemic syndromes. Circulation. 1988;77:1213-1220.
42. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis: characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J. 1983;50:127-134.
43. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20:1262-1275.
44. Kume T, Akasaka T, Kawamoto T, et al. Measurement of the thickness of the fibrous cap by optical coherence tomography. Am Heart J. 2006;152:755e1-755e4.
45. Tearney GJ, Jang IK, Bouma BE. Optical coherence tomography for imaging the vulnerable plaque. J Biomed Opt. 2006;11:021002.
46. Yun SH, Boudoux C, Tearney GJ, Bouma BE. High-speed wavelength-swept semiconductor laser with a polygon-scanner-based wavelength filter. Opt Lett. 2003;28:1981-1983.
47. de Boer JF, Cense B, Park BH, Pierce MC, Tearney GJ, Bouma BE. Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography. Opt Lett. 2003;28:2067-2069.
48. Tearney GJ, Waxman S, Shishkov M, et al. Three-dimensional coronary artery microscopy by intracoronary optical frequency domain imaging. JACC Cardiovasc Imaging. 2008;1:752-761.
49. Jang IK, Tearney GJ, MacNeill B, et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation. 2005;111:1551-1555.
50. Kubo T, Imanishi T, Takarada S, et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol. 2007;50:933-939.
51. Tanaka A, Imanishi T, Kitabata H, et al. Morphology of exertion-triggered plaque rupture in patients with acute coronary syndrome: an optical coherence tomography study. Circulation. 2008;118:2368-2373.
52. Tanaka A, Imanishi T, Kitabata H, et al. Distribution and frequency of thin-capped fibroatheromas and ruptured plaques in the entire culprit coronary artery in patients with acute coronary syndrome as determined by optical coherence tomography. Am J Cardiol. 2008;102:975-979.
53. Fujii K, Masutani M, Okumura T, et al. Frequency and predictor of coronary thin-cap fibroatheroma in patients with acute myocardial infarction and stable angina pectoris a 3-vessel optical coherence tomography study. J Am Coll Cardiol. 2008;52:787-788.
54. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J. 1993;69:377-381.
55. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.
56. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001;104:365-372.
57. Moreno PR, Lodder RA, Purushothaman KR, Charash WE, O'Connor WN, Muller JE. Detection of lipid pool, thin fibrous cap, and inflammatory cells in human aortic atherosclerotic plaques by near-infrared spectroscopy. Circulation. 2002;105:923-927.
58. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92: 657-671.
59. Arbustini E, Grasso M, Diegoli M, et al. Coronary atherosclerotic plaques with and without thrombus in ischemic heart syndromes: a morphologic, immunohistochemical, and biochemical study. Am J Cardiol. 1991;68:36B-50B.
60. Sano T, Tanaka A, Namba M, et al. C-reactive protein and lesion morphology in patients with acute myocardial infarction. Circulation. 2003;108:282-285. (Pubitemid 36899017)
61. Fukuda D, Shimada K, Tanaka A, et al. Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris. Am J Cardiol. 2006;97:175-180.
62. Tearney GJ, Yabushita H, Houser SL, et al. Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation. 2003;107:113-119.
63. Bouma BE, Tearney GJ, Yabushita H, et al. Evaluation of intracoronary stenting by intravascular optical coherence tomography. Heart. 2003;89:317-320.
64. Kubo T, Imanishi T, Kitabata H, et al. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study. JACC Cardiovasc Imaging. 2008;1:475-484.
65. Tanaka A, Imanishi T, Kitabata H, et al. Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study. Eur Heart J. 2009;30:1348-1355.
66. Takarada S, Imanishi T, Kubo T, et al. Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: assessment by optical coherence tomography study. Atherosclerosis. 2009;202:491-497.